| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.10. | Polarean shares plunge as board launches strategic review | 1 | Sharecast | ||
| 22.10. | AIM WINNERS & LOSERS: System1 sees lower sales; Polarean mulls delist | 1 | Alliance News | ||
| 22.10. | Polarean Imaging PLC - Strategic review and consideration of AIM listing | - | RNS | ||
| 06.10. | Polarean Imaging expands partnership with Ascend to cover 19 US states | 1 | Alliance News | ||
| POLAREAN IMAGING Aktie jetzt für 0€ handeln | |||||
| 06.10. | Polarean Imaging PLC - Ascend Imaging agreement expansion | - | RNS | ||
| 29.09. | Polarean announces new deal with Virginia hospital | 1 | Sharecast | ||
| 29.09. | Polarean Imaging: University of Virginia Health Hospital agreement | - | RNS | ||
| 25.09. | Polarean Imaging: US-Gesundheitsbehörde NIH bestellt Lungen-Bildgebungssystem | 1 | Investing.com Deutsch | ||
| 25.09. | National Institutes of Health orders Polarean's lung imaging system | 1 | Investing.com | ||
| 25.09. | Polarean Imaging PLC - National Institutes of Health system order | 1 | RNS | ||
| 25.09. | Polarean Imaging PLC - Half-year Report | - | RNS | ||
| 16.09. | Polarean Imaging PLC - Notice of Results | - | RNS | ||
| 12.08. | AIM Market Roundup: Fiinu, T42 IOT, Polarean | 2 | The Armchair Trader | ||
| 12.08. | Polarean Imaging PLC - Submission of new Phase III study protocol to FDA | - | RNS | ||
| 24.06. | Polarean Imaging PLC - Promotion & sales representative agreement | 3 | RNS | ||
| 09.06. | Polarean Imaging PLC - Result of AGM | - | RNS | ||
| 02.06. | Polarean: FDA expands XENOVIEW indication to include children from six years of age | 1 | GlobeNewswire (USA) | ||
| 02.06. | Polarean Imaging gets go-ahead to expand Xenoview use | 1 | Sharecast | ||
| 02.06. | Polarean Imaging PLC - FDA expands XENOVIEW indication | - | RNS | ||
| 21.05. | Polarean Imaging PLC - Dr. Bastiaan Driehuys awarded by ATS | - | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 78,76 | -0,40 % | Medtronic: Medicare Now Covers Breakthrough Technology To Treat Uncontrolled High Blood Pressure | NORTHAMPTON, MA / ACCESS Newswire / October 29, 2025 / MedtronicDecision means millions of Americans have access to the Medtronic Symplicity Spyral renal denervation systemEdwin Jimenez knows a thing... ► Artikel lesen | |
| HCA HEALTHCARE | 403,20 | -0,17 % | HCA Healthcare Raises 2025 Guidance | WASHINGTON (dpa-AFX) - HCA Healthcare (HCA) said, for 2025, the company now expects EPS in a range of $27.00 to $28.00, updated from prior guidance range of $25.50 to $27.00. Revenues are now... ► Artikel lesen | |
| LANTHEUS | 48,020 | -0,33 % | Lantheus Holdings, Inc.: Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer's Disease | BEDFORD, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight... ► Artikel lesen | |
| ENVISTA | 17,400 | -3,87 % | Envista Holdings Corporation: Envista Reports Third Quarter 2025 Results | BREA, Calif., Oct. 29, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended September 26, 2025."This was another strong quarter... ► Artikel lesen | |
| CAREDX | 12,160 | -2,95 % | CareDx, Inc. - 8-K, Current Report | ||
| GT BIOPHARMA | 0,600 | 0,00 % | GT Biopharma files to sell 14.59M shares of common stock for holders | ||
| SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Fourth Quarter and Fiscal Year 2025 Results | Reports 36% YoY Platform Revenue Increase, ARR of $20.9 Million and Record Fiscal Year Net Income and Adjusted EBITDA
HENDERSON, Nev., Sept. 18, 2025 /PRNewswire/... ► Artikel lesen | |
| CARMAT | 0,099 | -100,00 % | CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025) | Regulatory News:
CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from... ► Artikel lesen | |
| CHEMOMETEC | 105,40 | +0,96 % | Chemometec A/S: Upgrade of guidance | ANNOUNCEMENT NO. 295 28 October 2025 Upgrade of guidance ChemoMetec experiences an increased interest in its technology, not the least the XcytoMatic platform, and consequently expects a positive... ► Artikel lesen | |
| ARRAIL GROUP | 0,206 | 0,00 % | ARRAIL GROUP (06639): POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON SEPTEMBER 26, 2025 | ||
| DEVYSER DIAGNOSTICS | 12,200 | -0,97 % | Devyser Diagnostics AB: Bulletin from an Extraordinary General Meeting in Devyser Diagnostics AB (publ) held on 22 September 2025 | An Extraordinary General Meeting of Devyser Diagnostics AB (publ) ("Devyser" or the "Company") was held on Monday, 22 September 2025 at Bränningevägen 12, 120 54 Årsta. The main resolution passed at... ► Artikel lesen | |
| PROMIMIC | 1,175 | 0,00 % | Curiteva & Promimic - Bonded by Innovation | HUNTSVILLE, ALABAMA / ACCESS Newswire / May 6, 2025 / Curiteva, a leader in 3D-printed Trabecular PEEK implant technology, is pleased to announce an expanded partnership with Promimic, pioneers in nanotechnology... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 46,780 | -0,09 % | Laufende Fusionskontrollverfahren: Fresenius Medical Care Deutschland GmbH /Erwerb von Gewerbeimmobilien der Fresenius Immobilien Verwaltung Objekt Schweinfurt GmbH und der Fresenius Immobilien Verwaltung Objekt St. Wendel GmbH (jeweils Bad Homburg) | Datum der Anmeldung:20.10.2025Aktenzeichen:B1-144/25Unternehmen:Fresenius Medical Care Deutschland GmbH/Erwerb von Gewerbeimmobilien der Fresenius Immobilien Verwaltung Objekt Schweinfurt GmbH und der... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 48,970 | -0,77 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS | 50,52 | -0,08 % | Fresenius: Etwas mehr Optimismus für 2025 | Am 5. November gibt es von Fresenius die Zahlen zum dritten Quartal. Die Analysten der Deutschen Bank rechnen mit einem soliden Wachstum. Sie erwarten ein organisches Umsatzplus von 4 Prozent. Bei der... ► Artikel lesen |